Is there a third line option after chemotherapy and TKI failure in advanced non-small cell lung cancer?

Por De Grève, Jacques, Decoster, Lore, van Brummelen, David, Geers, Caroline, Schallier, Denis
Publicado no Transl Lung Cancer Res (2012)

Multi-targeted tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: an era of individualized therapy

Por Zhou, Caicun
Publicado no Transl Lung Cancer Res (2012)

Updating advances on recombinant human endostatin combined with radiotherapy for non-small cell lung cancer with brain metastasis

Por Jiang, Xiao-dong, Qiao, Yun
Publicado no Transl Lung Cancer Res (2012)

Clinical experiences of combining immunotherapy and radiation therapy in non-small cell lung cancer: lessons from melanoma

Por Kalbasi, Anusha, Rengan, Ramesh
Publicado no Transl Lung Cancer Res (2017)

Tumor heterogeneity: evolution through space and time in EGFR mutant non small cell lung cancer patients

Por Majem, Margarita, Remon, Jordi
Publicado no Transl Lung Cancer Res (2013)

State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer

Por Inno, Alessandro, Di Noia, Vincenzo, D’Argento, Ettore, Modena, Alessandra, Gori, Stefania
Publicado no Transl Lung Cancer Res (2016)

EphA2 targeted intratumoral therapy for non-small cell lung cancer using albumin mesospheres

Por Lee, Hung-Yen, Mohammed, Kamal A, Kaye, Fredric, Moudgil, Brij M, Nasreen, Najmunnisa
Publicado no Am J Transl Res (2017)

KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients

Por Garzón, Mónica, Villatoro, Sergi, Teixidó, Cristina, Mayo, Clara, Martínez, Alejandro, de los Llanos Gil, Maria, Viteri, Santiago, Morales-Espinosa, Daniela, Rosell, Rafael
Publicado no Transl Lung Cancer Res (2016)

Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals

Por Cui, Jiu-Wei, Li, Wei, Han, Fu-Jun, Liu, Yu-Di
Publicado no Transl Lung Cancer Res (2015)

Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis

Por Jin, Jiajia, Zhan, Ping, Qian, Hong, Wang, Xiaoxia, Katoh, Masaru, Phan, Kevin, Chung, Jin-Haeng, Lv, Tangfeng, Song, Yong
Publicado no Transl Lung Cancer Res (2016)

Clinical outcomes of CyberKnife stereotactic radiosurgery for elderly patients with presumed primary stage I lung cancer

Por Wang, Zhen, Li, Ao-Mei, Gao, Jie, Li, Jing, Li, Bing, Lee, Percy, Simone, Charles B., Song, Yong, Zhu, Xi-Xu
Publicado no Transl Lung Cancer Res (2017)

Serum Dickkopf-1 (DKK1) is significantly lower in patients with lung cancer but is rapidly normalized after treatment

Por Xu, Heng, Wu, Jianzhong, Chen, Bo, Li, Meng, Tian, Yanna, He, Mingfang, Xue, Jing, Wang, Jiangnan, Bai, Shan, Sharma, Ashok, Liu, Haitao, Tang, Jinhai, She, Jin-Xiong
Publicado no Am J Transl Res (2014)

The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer

Por Wang, Shu, Yu, Bing, Ng, Chiu Chin, Mercorella, Belinda, Selinger, Christina I., O’Toole, Sandra A., Cooper, Wendy A.
Publicado no Transl Lung Cancer Res (2015)

‘One-stop shop’: lung cancer patients’ and caregivers’ perceptions of multidisciplinary care in a community healthcare setting

Por Kedia, Satish K., Ward, Kenneth D., Digney, Siri A., Jackson, Bianca M., Nellum, April L., McHugh, Laura, Roark, Kristina S., Osborne, Orion T., Crossley, Fayre J., Faris, Nicholas, Osarogiagbon, Raymond U.
Publicado no Transl Lung Cancer Res (2015)

Prognostic significance of β-catenin expression in patients with non-small cell lung cancer: a meta-analysis

Por Jin, Jiajia, Zhan, Ping, Katoh, Masaru, Kobayashi, Susumu S., Phan, Kevin, Qian, Hong, Li, Huijuan, Wang, Xiaoxia, Wang, Xihua, Song, Yong
Publicado no Transl Lung Cancer Res (2017)

Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer

Por Zhang, Xiaoxue, Zhang, Rong, Zheng, Yuanjie, Shen, Jianfei, Xiao, Dakai, Li, Jin, Shi, Xiaoshun, Huang, Liyan, Tang, Hailing, Liu, Jun, He, Jianxing, Zhang, Haibo
Publicado em 2013

Myocyte enhancer factor 2D provides a cross-talk between chronic inflammation and lung cancer

Por Zhu, Hai-xing, Shi, Lin, Zhang, Yong, Zhu, Yi-chun, Bai, Chun-xue, Wang, Xiang-dong, Zhou, Jie-bai
Publicado no J Transl Med (2017)

Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung Cancer

Por Zahra, Amir, Chang, Tangel, Hejleh, Taher Abu, Furqan, Muhammad, Clamon, Gerald H., Bhatia, Sudershan K., Watkins, John M., Mott, Sarah L., Ahmann, Logan L., Bodeker, Kellie L., Spitz, Douglas R., Buatti, John M., Allen, Bryan G.
Publicado no J Oncol Transl Res (2016)

Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer

Por Zhai, Haoran, Zhong, Wenzhao, Yang, Xuening, Wu, Yi-Long
Publicado no Transl Lung Cancer Res (2015)

P46. Use of 18-FDG PET/CT in the radiotherapy planning of lung cancer—our updated experiences

Por Masarykova, Andrea, Scepanovic, Danijela, Povinec, Pavol, Bires, Pavol, Pobijakova, Margita
Publicado no Transl Lung Cancer Res (2014)